跳至主要内容
临床试验/EUCTR2006-005206-31-SE
EUCTR2006-005206-31-SE进行中(未招募)不适用

Perioperative Morbidity in Elderly patients undergoing Surgery for Fracture Neck of Femur. The Effect of Plasma or Ocplex® for reversal of Warfarin anticoagulation.

Örebro University Hospital0 个研究点开始时间: 2006年12月12日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Patients with fractured neck of femur judged to be medically operable.
  • - Age > or = 65 years.
  • - Taking warfarin anticoagulation due to atrial fibrillation, deep vein thrombosis or lung embolism, except for those patients who are in the control group.
  • - Have signed and dated Informed Consent.
  • - Willing and able to comply with the protocol for the duration of the trial.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Hypersensitive or allergic to the active substance or supporting substances in Ocplex®.
  • - Known allergy to heparin or history of heparin induced thrombocytopenia.
  • - Patients who are on warfarin sodium due to prosthetic valve surgery.
  • - Patients with other coagulation abnormalities or bleeding diathesis that may affect perioperative bleeding e.g. hemophilia, thrombocytopenia etc.
  • - Patients with dementia or other neuro-psychiatric condition, and judged by the investigator not to be able to comply with the protocol.
  • - Participation in another clinical trial.
  • - Patients who have been administered plasma within 48 hours.
  • - Patients who have hade a recent history of lung embolism or myocardial infarction.

研究者

发起方
Örebro University Hospital

相似试验